On admission time, median mRS scores in the NAC- and placebo-treated groups were 3 (IQR 4–2) and 2 (IQR 3–1) respectively, and the group difference in the score of mRS did not reach statistical significance before drug intervention ( Table 2 ).
← all excerpts
Evidence for a Beneficial Effect of Oral N-acetylcysteine on Functional Outcomes and Inflammatory Biomarkers in Patients with Acute Ischemic Stroke.
1
—
—